P913: LOW-DOSE BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH NIROGACESTAT VS BELAMAF MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1/2 DREAMM-5 PLATFORM SUB-STUDY 3

Detalles Bibliográficos
Autores principales: Callander, Natalie, Richardson, Paul, Hus, Marek, Ribrag, Vincent, Martinez-Lopez, Joaquín, Kim, Kihyun, Hoon Lee, Jae, Dimopoulos, Meletios A., Schjesvold, Fredrik, Facon, Thierry, Jo, Jae-Cheol, Min, Chang-Ki, Mielnik, Michał, Cheng, Shinta, Smith, Mary, Breitbach, Caroline J., Brawley, Chris, Sembhi, Harjeet, Lamacchia, John, Grosicki, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431067/
http://dx.doi.org/10.1097/01.HS9.0000970556.97221.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431067/
http://dx.doi.org/10.1097/01.HS9.0000970556.97221.22

Ejemplares similares